Lexpos News

/Lexpos News

RPS publishes Vision for Pharmacy Professional Practice in England

The Royal Pharmaceutical Society (RPS) has published a ten-year vision for the future of pharmacy professional practice in England. The vision, which was co-produced by The King’s Fund, explores how pharmacy teams in all care settings can support improved care for patients and help to address the many health challenges facing the country. It calls for [...]

The post RPS publishes Vision for Pharmacy Professional Practice in England appeared first on PSNC Website.

By |December 16th, 2022|Lexpos News|Comments Off on RPS publishes Vision for Pharmacy Professional Practice in England

Three SSPs issued for Phenoxymethylpenicillin (Pen V) oral solution

In response to significant ongoing disruption affecting supply of Phenoxymethylpenicillin oral solution, the Department of Health and Social Care (DHSC) has issued three new Serious Shortage Protocols (SSPs). The SSPs, introduced with immediate effect, allow community pharmacists to consider different options to enable continued supply of Phenoxymethylpenicillin to mitigate the ongoing supply disruptions affecting this [...]

The post Three SSPs issued for Phenoxymethylpenicillin (Pen V) oral solution appeared first on PSNC Website.

By |December 15th, 2022|Lexpos News|Comments Off on Three SSPs issued for Phenoxymethylpenicillin (Pen V) oral solution

Antibiotic supply and pricing issues: Steps taken this week

Following on from our update about antibiotic supply and pricing issues on Friday 9th December, we wanted to share some recent developments. HDA statement The Healthcare Distribution Association (HDA), whose member companies distribute over 90% of prescription medicines on behalf of the NHS, has issued a lengthy statement regarding the availability of Strep A treatments. [...]

The post Antibiotic supply and pricing issues: Steps taken this week appeared first on PSNC Website.

By |December 14th, 2022|Lexpos News|Comments Off on Antibiotic supply and pricing issues: Steps taken this week

Co-beneldopa (including Madopar®) preparations re-classified as special containers

Update (30/01/2023) – Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of all Co-beneldopa capsules and tablets. In December 2022, PSNC advised that the special container rules apply to all branded or generically written prescriptions for Madopar® dispensed from December 2022 onwards (except for generically prescribed Co-beneldopa 12.5mg/50mg [...]

The post Co-beneldopa (including Madopar®) preparations re-classified as special containers appeared first on PSNC Website.

By |December 14th, 2022|Lexpos News|Comments Off on Co-beneldopa (including Madopar®) preparations re-classified as special containers

Medicine Supply Notification: Antibiotics for the treatment of Group A Strep

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Antibiotics for the treatment of Group A Strep. MSN/2022/105 Tier 2 – medium impact Date of issue 12th December 2022 Supplies of antibiotics for the treatment of Group A Strep have seen a surge in demand and may be temporarily in [...]

The post Medicine Supply Notification: Antibiotics for the treatment of Group A Strep appeared first on PSNC Website.

By |December 12th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Antibiotics for the treatment of Group A Strep